课题基金 / 基金详情

项目摘要

项目成果

Thomas C. Shea的其他基金

相似基金

相关文献

中文摘要
翻译
北卡罗来纳大学教堂山分校(UNC-CH)在过去四年中每年招收约65个治疗案例(包括10-15个少数族裔应计费用/年),外加50-120个同伴研究。我们的附属网络负责另外78-99个治疗应计项目/年,同时保持出色的数据质量控制。北卡罗来纳大学在乳房、癌症预防和控制、胃肠道疾病、淋巴瘤、分子病理学、制药学和实验治疗、放射肿瘤学和移植等领域拥有广泛的领导地位,是北卡罗来纳大学少数民族倡议计划和VCU少数民族合作伙伴计划的研究基地。在过去五年中,北大西洋公约组织有4名委员会主席、8名委员会副主席、7名行政委员会成员、14名模式委员会成员或模式委员会联络员、14名科学委员会成员或科学委员会联络员、2名执行委员会成员、2名董事会成员和7名礼宾首席调查员。来自北卡罗来纳大学及其附属机构的成员主持了35项以上的研究,并为130多份手稿和摘要做出了贡献。北卡罗来纳大学-CH分校的教师扩大了我们在乳房、外科、GU、GI、淋巴瘤、实体肿瘤相关科学、胸科和PET委员会(L.Carey、C.Dees、L.Dressler、R.Goldberg、H McLeod、B.O‘Neil、R.Pruthi、C.Sartor、T.Shea和M.Socinski)的承诺和集团领导力。GI委员会主席Goldberg博士、PET委员会副主席Howard McLeod和乳房委员会副主席Charles Perou的加入大大加强了我们在集团中的角色。因此,我们认为,此次续签申请反映了UNC-CH调查人员在领导力、科学和服务方面为集团提供的日益重要的贡献,以及我们在保持对高质量数据提交的严格控制的同时,通过UNC-CH和附属成员增加应计利润的持续努力。
英文摘要
The University of North Carolina at Chapel Hill (UNC-CH) has enrolled approximately 65 treatment cases (including 10-15 minority accruals/year) plus 50-120 companion studies annually for the past four years. Our affiliate network is responsible for another 78-99 treatment accruals/year while maintaining excellent data quality control. UNC has broad leadership participation in the Group in Breast, Cancer Prevention and Control, GI, Lymphoma, Molecular Pathology, Pharmaceutics and Experimental Therapeutics, Radiation Oncology and Transplant, and is the research base for a UNC based Minority Initiative Program and a VCU based Minority CCOP. During the past five years, UNC has had four committee chairs, eight committee vice-chairs, seven administrative committee members, 14 modality committee members or modality committee liaisons, 14 scientific committee members or scientific committee liaisons, two Executive Committee members, two members of the Board of Directors, and seven protocol principal investigators. Members from UNC and its affiliates have chaired more than 35 studies and contributed to over 130 manuscripts and abstracts. Faculty at UNC-CH have expanded our commitment and Group leadership in the Breast, Surgery, GU, GI, Lymphoma, Solid Tumor Correlative Sciences, Thoracic, and PET committees (L. Carey, C. Dees, L. Dressler, R. Goldberg, H McLeod, B. O'Neil, R. Pruthi, C. Sartor, T. Shea, and M. Socinski). The addition of Drs. Goldberg (Chair, GI Committee), Howard McLeod (Vice Chair, PET Committee), and Charles Perou (Vice Chair, Breast Committee), have significantly enhanced our role in the Group. We therefore believe that this renewal application reflects the growing and crucial contribution that UNC-CH investigators provide to the Group in leadership, science, and service as well as our continued efforts to increase accrual both at UNC-CH and through affiliate members while maintaining rigorous control of quality data submission.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.
低强度同种异体移植可为晚期惰性 B 细胞恶性肿瘤患者提供较高的无事件生存率和总体生存率:CALGB 109901。
DOI: 10.1016/j.bbmt.2011.01.016
发表时间: 2011
期刊: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
影响因子: --
作者: [Shea,Thomas, Johnson,Jeffrey, Westervelt,Peter, Farag,Sherif, McCarty,John, Bashey,Asad, Isola,Luis, Baxter-Lowe,Lee-Anne, Kelly,Michael, Owzar,Kouros, Linker,Charles, CancerandLeukemiaGroupB]
通讯作者: CancerandLeukemiaGroupB
DOI: 10.1007/s10549-016-4051-1
发表时间: 2017-01
期刊: Breast cancer research and treatment
影响因子: 3.8
作者: [Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HB]
通讯作者: Muss HB
DOI: 10.1001/jama.2017.11470
发表时间: 2017-09-12
期刊: JAMA
影响因子: --
作者: [Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M]
通讯作者: Morrow M
Immunohistochemical detection of occult lymph node metastases in non-small cell lung cancer: anatomical pathology results from Cancer and Leukemia Group B Trial 9761.
非小细胞肺癌隐匿性淋巴结转移的免疫组织化学检测:癌症和白血病 B 组试验 9761 的解剖病理学结果。
DOI: --
发表时间: 2003
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者: [Vollmer,RobinT, Herndon2nd,JamesE, D'Cunha,Jonathan, Abraham,NaifZ, Solberg,Joette, Fatourechi,Mitra, Maruska,Ann, Kern,JeffreyA, Green,MarkR, Kratzke,RobertA, Maddaus,MichaelA, CancerandLeukemiaGroupBTrial9761]
通讯作者: CancerandLeukemiaGroupBTrial9761
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM
FILGRASTIM ALONE OR IN COMBINATION W/ R METHUSCF IN BREAST CANCER
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
PHARMACODYNAMIC MODELING OF ORAL ETOPOSIDE IN RELAPSED NON HODGKINS
海外基金